ArticleMedicine2019
Efficacy and tolerability of initial low-dose lenvatinib to treat differentiated thyroid cancer.
Haruhiko Yamazaki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled itcites it